Shots:

• The P-III STRATA2016 study involves assessing of StrataGraft treatment vs SoC (autograft) in 71 patients with deep partial-thickness thermal burns aged ≥18yrs. across 12 clinical sites in the US
• The P-III STRATA2016 study resulted in meeting both 1EPs ie- 98% reduction in the area requiring autograft and burn wounds achieved durable wound closure at the treatment site at three months post-placement (83% vs 86%)
• StrataGraft regenerative tissue is an investigational treatment for reducing autograft in patients with severe thermal burns with its expected BLA submission in H1’20 and is being evaluated in P-II study for full-thickness burns with its anticipated onset of a pediatric study in H2’19

Click here to­ read full press release/ article | Ref: Mallinckrodt | Image: WSJ